A jury had previously found that certain Boston Scientific balloon catheters and stent delivery systems infringed three Medtronic patents and that the patents were valid. The jury awarded damages of $250 million.
As a result of this decision, the damages are reduced to approximately $19 million. Following a prior decision by the court, Medtronic and Boston Scientific had already agreed to reduce the jury verdict to approximately $186 million.
Boston Scientific plans to appeal the remaining $19 million damage award to the US Court of Appeals for the Federal Circuit in Washington, DC. The company is confident it will prevail on appeal.